SKIP TO CONTENT
Industries
04

Industry

Healthcare & Life Sciences.

Outcomes economics, not throughput economics.

Overview

Strategy work for providers, payors, biotech, and medtech as the system shifts from volume and toward outcomes, AI-augmented diagnostics, and platform-based care.

Healthcare is moving from a throughput economy to an outcomes economy. Providers, payors, and life-sciences companies are being asked to deliver more under tighter constraints, with AI rewriting the cost curve of diagnosis, drug discovery, and back-office.

We work across the system on portfolio strategy, operating-model redesign, and the data and AI foundations that let outcomes-based models actually work.

Where we work

AI-augmented care

Clinical decision support, diagnostics, and workflow AI deployed safely and at scale.

Provider economics

Productivity, workforce, and operating-model redesign under chronic margin pressure.

Biotech & pharma platforms

Pipeline strategy, platform plays, and the build-vs-partner choices in AI-driven discovery.

Health data & sovereignty

Data architecture, consent, and governance for health systems and the companies that serve them.

Engagements

  • 01Provider strategy and operating-model reviews
  • 02Biotech platform and pipeline strategy
  • 03Medtech go-to-market and channel design
  • 04AI governance and clinical assurance programs

Questions we work on

  • What is our economic model when outcomes — not encounters — get paid?
  • Where does AI bend the cost curve, and where does it just add risk?
  • Which platforms compound, and which become commodity?
  • What data do we need to own to compete in the next decade?

Engagements begin with a private conversation.

Engage with Us